Length 
162 pages 

Date published 
February 2007 

Additional info 
Single-site, country, and global licenses are multi-user, searchable, and cut-and-paste ready PDFs delivered by e-mail.

For Corporate Subscriptions, Multi-Reports Orders, Discounts or Order Questions.  

Contact:
Kerri Kelley
Customer Service
781-972-1347 



Cytokine Therapies and Inhibitors Tables and Figures

Cytokine Therapies and Inhibitors: A Vibrant Pipeline and Active Approved Market 

Mark C. Via

Table 1.1. Overview of the Interleukins
Table 1.2. CC, C, CXC, and CX3C Chemokine/Receptor Families
Table 2.1. Interleukin Therapeutics That Are Approved or in Clinical Trials
Table 2.2. Interferon Therapeutics That Are Approved or in Clinical Trials
Table 2.3. TNF Therapeutics in Clinical Trials
Table 2.4. Hematopoietic Growth Factor Therapeutics That Are Approved or in Clinical Trials
Table 3.1. Interleukin Inhibitors That Are Approved or in Clinical Trials
Table 3.2. Interferon Inhibitors in Clinical Trials
Table 3.3. TNF Inhibitors That Are Approved or in Clinical Trials
Table 3.4. TGF-? Inhibitors in Clinical Trials
Table 3.5. Chemokine Antagonists in Clinical Trials
Table 4.1. Sales of Selected Cytokine-Based Drugs, 2004 and 2005
Table 4.2. Estimated New Cancer Cases in the United States, Total and Selected Types, 2006